Acquiring Company
Continuity Biosciences
Acquired Company
Focal Medical
BradentonCaryBiotechnologyBiotechnologyDescription
Continuity Biosciences, LLC has announced the acquisition of Focal Medical, Inc., enhancing its position in the targeted therapeutics market. This acquisition includes Focal's patented technologies and scientific expertise. Both companies aim to improve treatment options for pancreatic cancer. The collaboration is expected to advance clinical applications of innovative therapies.
Quick answer
Continuity Biosciences is acquiring Focal Medical, announced June 4, 2025. Continuity Biosciences is based in Bradenton, Florida, United States.
- How much did Continuity Biosciences pay for Focal Medical?
- The deal value was not disclosed.
- What does Continuity Biosciences do?
- Continuity Biosciences, LLC is a biopharmaceutical company developing advanced drug delivery technologies that address the limitations of conventional therapeutic administration.
- Where are Continuity Biosciences and Focal Medical based?
- Continuity Biosciences is based in Bradenton, Florida, United States. Focal Medical is based in Cary, North Carolina, United States.
- Who are the decision-makers at Continuity Biosciences?
- Fundz holds 1 contact at Continuity Biosciences. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Other recent acquisitions in Biotechnology and Biotechnology
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- AbbVie to acquire Capstan Therapeutics (July 15, 2025)
- ICL Group acquires Lavie Bio's assets for agriculture (July 8, 2025)
- Concentra acquires Cargo for $4.38 per share (July 8, 2025)
- Teleflex finalizes acquisition of Biotronik's business (July 2, 2025)
- Galenica acquires Labor Team for diagnostics expansion (July 2, 2025)
- Esteve Pharmaceuticals acquires Caprelsa® from Sanofi (July 1, 2025)
Who to call at Continuity Biosciences, and when
When Continuity Biosciences changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day Continuity Biosciences raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Continuity Biosciences, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Continuity Biosciences. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Continuity Biosciences makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Frequently asked
Who acquired Focal Medical?
Focal Medical was acquired by Continuity Biosciences, based in Bradenton. The deal was reported on June 4, 2025. Continuity Biosciences, LLC is a biopharmaceutical company developing advanced drug delivery technologies that address the limitations of conventional therapeutic administration. Continuity Biosciences is privately held and operates in Biotechnology.
When did Continuity Biosciences acquire Focal Medical?
Continuity Biosciences's acquisition of Focal Medical was reported on June 4, 2025. Continuity Biosciences, LLC has announced the acquisition of Focal Medical, Inc., enhancing its position in the targeted therapeutics market. This acquisition includes Focal's patented technologies and scientific expertise. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Focal Medical do?
Focal Medical, Inc. develops energy-based chemotherapy delivery systems that enable direct application of drugs to tumor sites. Its mission is to improve efficacy and reduce toxicity in the treatment of solid tumors, with an initial focus on pancreatic cancer. It is privately held, operating in Biotechnology, and is based in Cary.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.